Literature DB >> 31445977

Dietary of n-3 polyunsaturated fatty acids influence neurotransmitter systems of rats exposed to unpredictable chronic mild stress.

Rong Yang1, Meng-Qi Zhang2, Ying Xue3, Rui Yang4, Mi-Mi Tang5.   

Abstract

Emerging evidence suggest that neuromodulators are the critical factor involved in depression. This study aimed to investigate the effects of unpredictable chronic mild stress (CUMS) and n-3 polyunsaturated fatty acids (n-3 PUFAs) on central nervous system. The depressive-like behaviors induced by CUMS were assessed by sucrose preference test (SPT), open field test (OFT) and forced swimming test (FST). High-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) was used to quantify the levels of neurotransmitters and their metabolites involved in serotonergic, dopaminergic, noradrenergic, GABAergic neurotransmitter systems in hippocampus and prefrontal cortex. Repeated CUMS caused depressive-like behaviors of rats, associated with the alteration of neurotransmitters in brain, including the decreasing DA level, the increasing NE and GABA level, and the increasing 5-HT turnover rate in hippocampus, which could be partly alleviated by sufficient n-3 PUFAs supplementation. The influence of stress and diet on neurotransmitters in the prefrontal cortex was slight. However, it was obvious that supplementary of n-3 PUFAs relieved the decreasing DA/NE between-metabolite ratio 1,2 and DA/5-HT between-metabolite ratio 1,2 in the prefrontal cortex caused by CUMS. Altered neurotransmitter turnover rates and between-metabolite ratios in brain may be better predictors in depression and antidepressant treatment compared with monoamine neurotransmitters.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Behaviors; Between-metabolite ratio; CUMS; Depression; Turnover rate; n-3 PUFAs

Mesh:

Substances:

Year:  2019        PMID: 31445977     DOI: 10.1016/j.bbr.2019.112172

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  N-3 PUFA Have Antidepressant-like Effects Via Improvement of the HPA-Axis and Neurotransmission in Rats Exposed to Combined Stress.

Authors:  Eun-Young Kim; Jeong-Eun Choi; Mijin Kim; Jisu Hong; Yongsoon Park
Journal:  Mol Neurobiol       Date:  2020-07-01       Impact factor: 5.590

Review 2.  Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system.

Authors:  Lie Zhou; Jia-Yao Xiong; Yu-Qian Chai; Lu Huang; Zi-Yang Tang; Xin-Feng Zhang; Bo Liu; Jun-Tao Zhang
Journal:  Front Psychiatry       Date:  2022-08-31       Impact factor: 5.435

3.  Omega-3 Polyunsaturated Fatty Acids Supplementation Alleviate Anxiety Rather Than Depressive Symptoms Among First-Diagnosed, Drug-Naïve Major Depressive Disorder Patients: A Randomized Clinical Trial.

Authors:  Rong Yang; Lu Wang; Kun Jin; Song Cao; Chujun Wu; Jimin Guo; Jindong Chen; Hui Tang; Mimi Tang
Journal:  Front Nutr       Date:  2022-07-12

4.  Mass spectrometry imaging of mice brain lipid profile changes over time under high fat diet.

Authors:  Daniela Cota; Boutayna Rhourri-Frih; Gianluca Sighinolfi; Samantha Clark; Landry Blanc
Journal:  Sci Rep       Date:  2021-10-04       Impact factor: 4.379

5.  Sex- and age- dependent effect of pre-gestational chronic stress and mirtazapine treatment on neurobehavioral development of Wistar rat offspring.

Authors:  Mireia Viñas-Noguera; Kristína Csatlósová; Eva Šimončičová; Ezster Bögi; Eduard Ujházy; Michal Dubovický; Kristína Belovičová
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

6.  Isoginkgetin treatment attenuated lipopolysaccharide-induced monoamine neurotransmitter deficiency and depression-like behaviors through downregulating p38/NF-κB signaling pathway and suppressing microglia-induced apoptosis.

Authors:  Peng Li; Fucheng Zhang; Yajuan Li; Cai Zhang; Zhiyou Yang; Yongping Zhang; Cai Song
Journal:  J Psychopharmacol       Date:  2021-07-19       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.